INTRODUCTION
Hepatoceullar carcinoma (HCC) is a common cause of cancer-related death and its incidence is increasing worldwide [1]. Egypt has a rising rate of HCC. The currently increasing incidence of HCC in Egyptians may be due to the increased prevalence of hepatitis C virus (HCV) as a primary risk factor [2] . Diabetes mellitus (DM) increased the risk of chronic non-alcoholic liver disease and HCC in male patients without concomitant liver disease [3] . Insulin resistance (IR) is a condition where body cells fail to respond to the normal actions of insulin leading to hyperglycemia [4] .
Steatohepatitis is associated with IR and characterized by inflammation, apoptosis of liver cells, fat and fibrotic tissue accumulation in the liver, which may progress to cirrhosis and HCC.
IR seems to play a fundamental role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) [5] .
Current data suggest that an alteration in the regulation of hepatocyte apoptosis could play an important role in hepatic damage, steatohepatisis and HCC progression [6] .
The HCV core protein induces insulin resistance by increasing tumor necrosis factor  which disturb tyrosine phosphorylation of insulin receptor substrate-1 thus, diabetes mellitus including insulin resistance seems to be closely associated with various liver diseases that can lead to HCC [7] .
Liver cell damage in chronic HCV infection is mediated by the induction of apoptosis. During apoptosis, there is an activation of specific intraceullar protesases (caspases) that able to cleave different substrates, including cytokeratin-18 (CK-18), a major inter-mediate filament protein in the liver. The action of these caspases shows a neoepitope in CK-18(M 30 ) which is not detectable in alive or necrotic cells [8] .
When surgery is not possible for HCC, there are several minimally invasive options for tumor ablation either chemical or thermal [9] [10] [11] . The most frequent event observed during the follow up of curatively treated HCC patients is intrahepatic recurrence [12] [13] [14] . Which may be either local tumor progression or intrahepatic distant recurrence [15] .
Radiofrequency ablation (RFA) is among therapies that offer a high rate of complete response and potential cure . RFA induces tumor destruction by heating the tumor tissue to a temperature that exceeds 60 o C. This heating is generated from a high frequency alternating current that is delivered through an electrode placed in the center of the tumor. The generated heat result in coagulative necrosis of the tumor tissue with denaturation of the intra-cellular proteins and dissolution of the cell membrane lipid bilayers [16] .
The objective of this study is to evaluate the impact of insulin resistance and cytokeratin 18 on HCC recurrence after initial treatment with RFA.
PATIENTS AND METHODS
The present study was carried out in Tropical Medicine, Radiotherapy, Clinical Pathology and Family Medicine Departments, Zagazig University. The study included 60 chronic HCV patients; the diagnosis of HCV was based on positive anti-HCV antibodies. Patients were divided into 2 groups: group I: 30 patients with HCV related HCC, group II: 30 patients with HCV related cirrhosis without HCC.
Exclusion criteria included diabetes mellitus, treatment with any medication known to affect glucose tolerance or insulin secretion, alcoholics, pregnant and breast feeding women.
This study was approved by the local Ethical Committee of Faculty of Medicine, Zagazig University and an informed written consent was obtained from each participant in the study.
All patients were subjected to the following:  Full history taking and clinical examination.
 Venous blood samples were taken from all patients, serum was separated from the cellular fraction via centrifugation at 5,000 RPM for 3 minutes. Serum samples were kept at-80°C till the time of assay. Serum CK-18 assay was performed using CK-18 M30 apoptosis ELISA assay (PEVIVA, Alexis, Günwald, Germany).
 HCVAb in serum was detected by ELISA third generation, using kit from ORTHO. Catalogue number; 631300942. 
Radiological investigations including:
a) Abdominal ultrasonography (US) to assess liver cirrhosis, hepatic focal lesions as regard its number, size and for needle guidance during percutaneous RFA [19] .
b) Triphasic CT scan to confirm the diagnosis of HCC, diagnosis of HCC based on the typical hypervascular tumor stain on angiography and typical dynamic-study findings of enhanced staining in the early phase and attenuation in the delayed phase [20] .
Tumor ablation:
The technique was started by a small puncture into the skin using a scalpel (No 11 
Follow up of therapy
Triphasic CT, HOMA-IR, serum AFP and CK-18 levels were performed at 1, 3 and 6 months after the last session of RFA to evaluate the response to treatment and its effect on these parameters.
Statistical Analysis
Data were collected, tabulated and statistically analyzed using SPSS 22.0 for windows (SPSS Inc., Chicago, IL, USA) & MedCalc 13 for windows (MedCalc Software bvba, Ostend, Belgium). Quantitative variables were expressed as mean ± SD and median (range). Mann Whitney U test was used to compare between two groups of independent non-normally distributed data.
Friedman test was used to compare more than two groups of dependent non-normally distributed data. The Spearman's rank correlation coefficient (r) was calculated to assess the relationship between CK-18 & selected study parameters. Receiver Operating Characteristic (ROC) curves were obtained to calculate the optimized cutoff point for CK-18, AFP, and HOMA-IR to reach the best compromise in the prediction of recurrence. The cutoff point with maximum sensitivity and specificity (validity) is used as the recommended cutoff point and also Area Under Curve (AUC) was calculated. Survival (S) was calculated as the time from diagnosis to death or the most recent follow-up contact (censored). Stratification of S was done according to CK-18 & HOMA-IR subgroups. These time-to-event distributions were estimated using the method of Kaplan-Meier plot, and compared using two-sided exact log-rank test. All tests were two sided with p<0.05 was considered statistically significant (S), p<0.01 was considered highly statistically significant (HS), and p>0.05 was considered non statistically significant (NS).
RESULTS
This study was conducted on 30 HCV related HCC patients and 30 HCV related cirrhotic patients. Their demographic, clinical and biochemical characteristics are shown in Table 1 . There was a statistically significant difference in the studied markers (AFP, CK-18 and HOMA-IR) among subgroups of Child classes as well as tumor size in HCC patients ( Table 2 ). There was positive significant correlation between CK-18 and maximum tumor diameter, AFP and HOMA-IR. Also, there was positive significant correlation between HOMA-IR and maximum tumor diameter and AFP (Table 3 & Figure 1 ).
After treatment with RFA, the level of HOMA-IR, CK18 and AFP showed significant reduction in the responded patients [1 month 26 patient, 3 months 21 patient and lastly, after 6 months 18 patients] (Table 4) .
Most patients with recurrent tumor were in Child class B and all patients with recurrence had maximum tumor diameter (3-5cm) (P<0.001). CK18 and HOMA-IR level were significantly increased in patients with recurrent HCC versus those without recurrence 324.8(317.9-340.9)] versus 308.5 (287.8-317.2) ng/ml, P<0.001 and 3-4(2.9-6.4) versus 2.3(1.29), P<0.001) respectively (Table 5 ).
According to receiver operating characteristic curve (ROC) the most accurate predictor of recurrence in HCC patients was CK-18 (Table 6 & Figure 2 ). Six months recurrence-free survival in total was 60% ( Table 7) . Analysis of the data using Kaplan-Meier estimates of survival probability for patients with serum CK-18 ≤318.9 ng/mL and HOMA-IR ≤2.7 showed significant longer free survival and higher overall survival probability when compared to CK-18> 318.9 and HOMA-IR>2.7 (p value=<0.001) ( Tables 7 and  8 , Figures 3 and 4) . Qualitative data are presented as number(%);*Chi-square test.; § Log rank test; p< 0.05 is significant. 
DISCUSSION
Hepatocellular carcinoma is a worldwide malignancy, and the incidence rate has increased significantly over the past few decades In the present study, there is a significant increase in CK18 level in HCC patients compared to cirrhotic patients. Moreover CK-18 was significantly higher in patients with recurrent tumor versus non recurrent. These could be explained by increase in the spontaneous apoptosis of HCC cells which released into blood vessels.
We have also observed significant increase of CK-18 level in large tumor size. This could be explained by the crosstalk between angiogenesis, cytokeratin-18, and insulin resistance [45] .
McHugh and co-workers found that microvascular invasion is strongly associated with the tumor size and AFP >100 ng/ml and greatly increase the risk of recurrence after transplantation for HCC [46] .
It is vital to assess patients' prognosis to determine the suitable treatment and improve the outcome thus we investigated risk factors of recurrence which could help in its prevention and follow up of patients. The present study revealed that Child class B, large tumor size (3-5cm), increased serum CK-18, AFP and HOMA-IR levels were risk factors that predict HCC recurrence Also, Lai et al. [47] found a strong correlation between AFP level, tumor dimensions and microvascular invasion which all are predictors of HCC recurrence. Carcinogenesis may develop when the homeostatic balance between cell survival and apoptosis is disturbed in our study; we found that the CK-18 and HOMA-IR response independently predicted the recurrence free survival (together with ChildPugh score and tumor size). We can expect more favorable prognosis in patients with CK-18 <317.2 and HOMA-IR had response than that of those with CK-18 >317 and HOMA-IR >2.7. The close observation of the non-response patients might be required to detect disease progression.
The main limitations of our study included small sample size in limited observation period and there was no correlation between tissue and serum CK-18 levels.
Finally, we can conclude that CK-18 correlates with HOMA-IR and is related to HCC size which makes them potential prognostic markers for follow up of patients after therapeutic strategies to predict recurrence of HCC.
